Reply to New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy by Guarda et al.

被引：0
|
作者：
Gonzalez-Gay, M. A. [1 ,2 ]
Hernandez, J. L. [2 ,3 ]
Blanco, R. [1 ,2 ]
机构：
[1] Hosp Univ Marques de Valdecilla, IDIVAL, Div Rheumatol, Ave Cardenal Herrera Oria S-N, Santander 39011, Spain
[2] Univ Cantabria, Dept Med, Santander, Spain
[3] Hosp Univ Marques de Valdecilla, IDIVAL, Dept Med, Santander, Spain
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2023年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：991 / 991
页数：1
相关论文
共 11 条
  • [1] New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. A comment on: Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients. by Calderon-Goercke et al.
    Guarda, M.
    Araoz, P. A.
    Ghaffar, U.
    Warrington, K. J.
    Koster, M. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (04) : 989 - 990
  • [2] Reply to: Superb microvascular imaging in giant cell arteritis by Conticini et al.
    SAKELLARIOU, G.
    GIOVANNINI, I.
    GRIGNASCHI, S.
    ZABOTTI, A.
    IAGNOCCO, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (04) : 862 - 862
  • [3] New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension
    Stone, John H.
    Spotswood, Helen
    Unizony, Sebastian H.
    Aringer, Martin
    Blockmans, Daniel
    Brouwer, Elisabeth
    Cid, Maria C.
    Dasgupta, Bhaskar
    Rech, Juergen
    Salvarani, Carlo
    Spiera, Robert
    Bao, Min
    RHEUMATOLOGY, 2022, 61 (07) : 2915 - 2922
  • [4] Tocilizumab in patients with giant cell arteritis: analysis of new-onset and relapsing subgroups from a randomized, double-blind, placebo-controlled, phase 3 trial
    Birchwood, Christine
    Tuckwell, Katie
    Dimonaco, Sophie
    Klearman, Micki
    Collinson, Neil
    Stone, John H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [5] EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENT SUBGROUPS WITH NEW-ONSET AND RELAPSING GIANT CELL ARTERITIS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL
    Stone, John H.
    Tuckwell, Katie
    Dimonaco, Sophie
    Klearman, Micki
    Aringer, Martin
    Blockmans, Daniel
    Brouwer, Elisabeth
    Cid, Maria C.
    Dasgupta, Bhaskar
    Rech, Juergen
    Salavarani, Carlo
    Spiera, Robert
    Unizony, Sebastian
    Collinson, Neil
    RHEUMATOLOGY, 2017, 56 : 11 - 12
  • [6] Reply to 'New-onset cutaneous lichen planus triggered by COVID-19 vaccination' by Merhy et al.
    Camela, E.
    Guerrasio, G.
    Patruno, C.
    Scalvenzi, M.
    Di Caprio, N.
    Fabbrocini, G.
    Napolitano, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (04) : E249 - E251
  • [7] Reply:: The right place of 18FDG PET for the diagnosis of giant cell arteritis -: A response to the article of Brodmann et al.
    Brodmann, M
    Pilger, E
    RHEUMATOLOGY, 2004, 43 (05) : 676 - 676
  • [8] Time to Flare in Patients With New-Onset Versus Relapsing Giant Cell Arteritis Treated With Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results From a Randomized Controlled Phase 3 Trial
    Stone, John H.
    Neumann, Thomas
    Spotswood, Helen
    Unizony, Sebastian H.
    Aringer, Martin
    Blockmans, Daniel
    Brouwer, Elisabeth
    Cid, Maria C.
    Dasgupta, Bhaskar
    Rech, Juergen
    Salvarani, Carlo
    Spiera, Robert
    Bao, Min
    SWISS MEDICAL WEEKLY, 2020, : 5S - 5S
  • [9] Time to Flare in Patients with New-Onset versus Relapsing Giant Cell Arteritis Treated with Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results from a Randomized Controlled Phase 3 Trial
    Stone, John
    Spotswood, Helen
    Unizony, Sebastian
    Aringer, Martin
    Blockmans, Daniel
    Brouwer, Elisabeth
    Cid, Maria C.
    Dasgupta, Bhaskar
    Rech, Juergen
    Salvarani, Carlo
    Spiera, Robert
    Bao, Min
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [10] New-onset cutaneous sarcoidosis under tocilizumab treatment for giant cell arteritis: a quasi-paradoxical adverse drug reaction. Case report and literature review
    Del Giorno, Rosaria
    Iodice, Alfonso
    Mangas, Cristina
    Gabutti, Luca
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2019, 11
12